DEREGULATION of cell proliferation is a hallmark of neoplastic transformation. Alteration in growth control pathways must translate into changes in the cell-cycle regulatory machinery, but the mechanism by which this occurs is largely unknown. Compared with normal human fibroblasts, cells transformed with a variety of viral oncoproteins show striking changes in the subunit composition of the cyclin-dependent kinases (CDKs)1. In normal cells, CDKs exist predominantly in multiple quaternary complexes, each containing a CDK, cyclin, proliferating cell nuclear antigen and the p21 protein. However, in many transformed cells, proliferating cell nuclear antigen and p21 are lost from these multiprotein enzymes. Here we have investigated the significance of this phenomenon by molecular cloning of p21 and in vitro reconstitution of the quaternary cell-cycle kinase complexes. We find that p21 inhibits the activity of each member of the cyclin/CDK family. Furthermore, over expression of p21 inhibits the proliferation of mammalian cells. Our results indicate that p21 may be a universal inhibitor of cyclin kinases.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Cell Death Discovery Open Access 27 June 2023
Inhibition of p21 activates Akt kinase to trigger ROS-induced autophagy and impacts on tumor growth rate
Cell Death & Disease Open Access 15 December 2022
Integrated analysis of the expression profiles of the lncRNA-miRNA-mRNA ceRNA network in granulosa and cumulus cells from yak ovaries
BMC Genomics Open Access 03 September 2022
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Xiong, Y., Zhang, H. & Beach, D. Genes Dev. 7, 1572–1583 (1993).
Sherr, C. Cell 73, 1059–1065 (1993).
Draetta, G. Trends biochem. Sci. 15, 378–383 (1990).
Xiong, Y., Zhang, H. & Beach, D. Cell 71, 505–514 (1992).
Zhang, H., Xiong, Y. & Beach, D. Molec. Biol. Cell 4, 897–906 (1993).
Matsushime, H. et al. Cell 71, 323–334 (1992).
Zhu, L. et al. Genes Dev. 7, 1111–1125 (1993).
Kastan, M. B. et al. Cell 71, 587–597 (1992).
Kawasaki, H., Emori, Y. & Suzuki, K. Analyt. Biochem. 191, 332–336 (1990).
Xiong, Y., Menninger, J., Beach, D. & Ward, D. Genomics 13, 575–584 (1992).
Hannon, G. J., Demetrick, D. & Beach, D. Genes Dev. 7, 2378–2391 (1993).
Draetta, G. & Beach, D. Cell 54, 17–26 (1988).
Ewen, M. E. et al. Cell 73, 487–497 (1993).
About this article
Cite this article
Xiong, Y., Hannon, G., Zhang, H. et al. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701–704 (1993). https://doi.org/10.1038/366701a0
This article is cited by
Cell Death Discovery (2023)
Long-term p21 and p53 dynamics regulate the frequency of mitosis events and cell cycle arrest following radiation damage
Cell Death & Differentiation (2023)
Therapeutic effects of hAMSCs secretome on proliferation of MDA-MB-231 breast cancer cells by the cell cycle arrest in G1/S phase
Clinical and Translational Oncology (2023)
Applied Biochemistry and Biotechnology (2023)